420 related articles for article (PubMed ID: 32365599)
1. Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies.
Coccaro N; Tota G; Anelli L; Zagaria A; Specchia G; Albano F
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365599
[TBL] [Abstract][Full Text] [Related]
2. Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia.
Della Starza I; De Novi LA; Santoro A; Salemi D; Tam W; Cavalli M; Menale L; Soscia R; Apicella V; Ilari C; Vitale A; Testi AM; Inghirami G; Chiaretti S; Foà R; Guarini A
Leuk Lymphoma; 2019 Nov; 60(11):2838-2840. PubMed ID: 31050551
[No Abstract] [Full Text] [Related]
3. Minimal Residual Disease Monitoring with Next-Generation Sequencing Methodologies in Hematological Malignancies.
Sánchez R; Ayala R; Martínez-López J
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185671
[TBL] [Abstract][Full Text] [Related]
4. Application of allele-specific quantitative PCR using genomic DNA to monitor minimal residual disease based on mutant gene levels following allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies: comparison of mutant levels with autologous DNA percentage by short tandem repeat-PCR.
Taira C; Matsuda K; Saito S; Sakashita K; Sugano M; Okumura N; Honda T
Clin Chim Acta; 2012 Feb; 413(3-4):516-9. PubMed ID: 22138486
[TBL] [Abstract][Full Text] [Related]
5. Clinical actionability of measurable residual disease (MRD) assessment in the management of patients with hematologic malignancies: a case-based monograph.
Wolf J; Fonseca R; Muffly L
Clin Adv Hematol Oncol; 2020 Mar; 18 Suppl 9(3):1-16. PubMed ID: 33843875
[TBL] [Abstract][Full Text] [Related]
6. Methods of minimal residual disease (MRD) detection in childhood haematological malignancies.
Jółkowska J; Derwich K; Dawidowska M
J Appl Genet; 2007; 48(1):77-83. PubMed ID: 17272865
[TBL] [Abstract][Full Text] [Related]
7. Applications of next-generation sequencing in hematologic malignancies.
Ramkissoon LA; Montgomery ND
Hum Immunol; 2021 Nov; 82(11):859-870. PubMed ID: 33648805
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of minimal residual disease in multiple myeloma.
Bai Y; Orfao A; Chim CS
Br J Haematol; 2018 Apr; 181(1):11-26. PubMed ID: 29265356
[TBL] [Abstract][Full Text] [Related]
9. An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemia.
Nunes V; Cazzaniga G; Biondi A
Expert Rev Mol Diagn; 2017 Nov; 17(11):953-963. PubMed ID: 28891364
[TBL] [Abstract][Full Text] [Related]
10. Quantification of the Mutant CALR Allelic Burden by Digital PCR: Application to Minimal Residual Disease Evaluation after Bone Marrow Transplantation.
Mansier O; Migeon M; Saint-Lézer A; James C; Verger E; Robin M; Socié G; Bidet A; Mahon FX; Cassinat B; Lippert E
J Mol Diagn; 2016 Jan; 18(1):68-74. PubMed ID: 26596525
[TBL] [Abstract][Full Text] [Related]
11. The Role of BEAMing and Digital PCR for Multiplexed Analysis in Molecular Oncology in the Era of Next-Generation Sequencing.
Denis JA; Guillerm E; Coulet F; Larsen AK; Lacorte JM
Mol Diagn Ther; 2017 Dec; 21(6):587-600. PubMed ID: 28667577
[TBL] [Abstract][Full Text] [Related]
12. Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR?
Cilloni D; Petiti J; Rosso V; Andreani G; Dragani M; Fava C; Saglio G
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067725
[TBL] [Abstract][Full Text] [Related]
13. Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.
Thol F; Gabdoulline R; Liebich A; Klement P; Schiller J; Kandziora C; Hambach L; Stadler M; Koenecke C; Flintrop M; Pankratz M; Wichmann M; Neziri B; Büttner K; Heida B; Klesse S; Chaturvedi A; Kloos A; Göhring G; Schlegelberger B; Gaidzik VI; Bullinger L; Fiedler W; Heim A; Hamwi I; Eder M; Krauter J; Schlenk RF; Paschka P; Döhner K; Döhner H; Ganser A; Heuser M
Blood; 2018 Oct; 132(16):1703-1713. PubMed ID: 30190321
[TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing-based minimal residual disease monitoring in patients receiving allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia or myelodysplastic syndrome.
Shapiro RM; Kim DDH
Curr Opin Hematol; 2018 Nov; 25(6):425-432. PubMed ID: 30281033
[TBL] [Abstract][Full Text] [Related]
15. dPCR application in liquid biopsies: divide and conquer.
Moreno-Manuel A; Calabuig-Fariñas S; Obrador-Hevia A; Blasco A; Fernández-Díaz A; Sirera R; Camps C; Jantus-Lewintre E
Expert Rev Mol Diagn; 2021 Jan; 21(1):3-15. PubMed ID: 33305634
[No Abstract] [Full Text] [Related]
16. Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies.
Lamy PJ; Castan F; Lozano N; Montélion C; Audran P; Bibeau F; Roques S; Montels F; Laberenne AC
J Mol Diagn; 2015 Jul; 17(4):366-73. PubMed ID: 25952101
[TBL] [Abstract][Full Text] [Related]
17. PCR for monitoring of minimal residual disease in hematologic malignancy.
Matsuda K; Sugano M; Honda T
Clin Chim Acta; 2012 Jan; 413(1-2):74-80. PubMed ID: 22057038
[TBL] [Abstract][Full Text] [Related]
18. Quantitative monitoring of single nucleotide mutations by allele-specific quantitative PCR can be used for the assessment of minimal residual disease in patients with hematological malignancies throughout their clinical course.
Taira C; Matsuda K; Kamijyo Y; Sakashita K; Ishida F; Kumagai T; Yamauchi K; Okumura N; Honda T
Clin Chim Acta; 2011 Jan; 412(1-2):53-8. PubMed ID: 20849840
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations.
Iwama E; Sakai K; Azuma K; Harada T; Harada D; Nosaki K; Hotta K; Ohyanagi F; Kurata T; Fukuhara T; Akamatsu H; Goto K; Shimose T; Kishimoto J; Nakanishi Y; Nishio K; Okamoto I
Ann Oncol; 2017 Jan; 28(1):136-141. PubMed ID: 28177428
[TBL] [Abstract][Full Text] [Related]
20. Minimal Residual Disease Analysis by Monitoring Immunoglobulin and T-Cell Receptor Gene Rearrangements by Quantitative PCR and Droplet Digital PCR.
Starza ID; Eckert C; Drandi D; Cazzaniga G;
Methods Mol Biol; 2022; 2453():79-89. PubMed ID: 35622321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]